Of note, the PC-3, Du145, and 22Rv1 cell lines represent models of advanced, androgen-independent prostate cancer with no androgen receptor (AR-null, PC-3, and Du145) expression or an androgen-insensitive AR variant (ARv7) co-expressed with a full-length AR (22Rv1). This evidence concerns the gene AR and prostate cancer.